ArticleChina CDC weekly2026
Associations Between Longitudinal Antenatal Hematological Indicators and Risk of Patent Ductus Arteriosus in Newborns - Beijing, China, 2011-2025.
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Patent ductus arteriosus (PDA) is closely associated with prematurity. Maternal conditions may increase offspring cardiac risk. However, antenatal hematological evidence remains limited. What is added by this report?: Among 68,945 singleton live births, 945 were diagnosed with PDA. After false discovery rate correction, trimester-specific indicators, particularly prothrombin time and thrombin time, were found to be associated with PDA risk. The patterns differed by preterm birth, hypertensive disorders of pregnancy, gestational diabetes mellitus, and conception mode. What are the implications for public health practice?: Routine maternal hematological indicators may provide preliminary evidence for further investigation of perinatal risk markers and may help identify pregnancies and newborns who may benefit from closer cardiovascular surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.